Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock · CUSIP: 03835L306
Event date: 2025-04-21
- Filing-level shares
- 277,000.00
- Percent of class
- 4.99%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 277,000.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001553350-25-000022
- Form type
- SCHEDULE 13G/A
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Apr 25, 2025
- Reporting period
- Apr 21, 2025
- Description
- Schedule 13G beneficial ownership